| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Tissue Culture, Institute for Cancer Research, The Norwegian Radium Hospital, N-0310 Oslo 3, Norway
The effect of cinnamaldehyde and various cinnamaldehyde derivatives on cell inactivation induced by cis-diamminedichloroplatinum(II) (cis-DDP) was investigated using human NHIK 3025 cells in culture. Cell inactivation was measured as a loss in the ability of single cells to give rise to macroscopic colonies following drug treatment. It was found that cinnamaldehyde and
-chlorocinnamaldehyde potentiated the cell-inactivating effect when used simultaneously with cis-DDP without increasing the amount of cell-associated platinum. In contrast, a protective effect with respect to cell inactivation was found when cells were treated with cis-DDP in combination with hydrocinnamaldehyde or
-methylcinnamaldehyde. At higher concentrations (>1 mM) all cinnamaldehyde derivatives reduced cellular uptake of cis-DDP. Therefore, while protection from cis-DDP-induced cell inactivation involves reduced platinum uptake, potentiation by cinnamaldehyde and cinnamaldehyde derivatives does not seem to be due to an increase in intracellular platinum. We propose that cinnamaldehyde may compete with cis-DDP in nucleophilic addition reactions involving intracellular sulfhydryls.
1 This work was supported by grants from the Norwegian Cancer Society.
2 Fellow of the Norwegian Cancer Society. To whom requests for reprints should be addressed.
Received 9/ 7/88. Revised 2/24/89. Accepted 4/13/89.
This article has been cited by other articles:
![]() |
J. Usta, S. Kreydiyyeh, P. Barnabe, Y. Bou-Moughlabay, and H. Nakkash-Chmaisse Comparative study on the effect of cinnamon and clove extracts and their main components on different types of ATPases Human and Experimental Toxicology, July 1, 2003; 22(7): 355 - 362. [Abstract] [PDF] |
||||
![]() |
I. I. Budihardjo, S. A. Boerner, S. Eckdahl, P. A. Svingen, R. Rios, M. M. Ames, and S. H. Kaufmann Effect of 6-Aminonicotinamide and Other Protein Synthesis Inhibitors on Formation of Platinum-DNA Adducts and Cisplatin Sensitivity Mol. Pharmacol., March 1, 2000; 57(3): 529 - 538. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |